Molecular Partners (Switzerland) Technical Analysis
MOLN Stock | CHF 4.60 0.17 3.84% |
As of the 7th of January, Molecular Partners secures the Downside Deviation of 5.16, mean deviation of 4.33, and Risk Adjusted Performance of 0.0524. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Molecular Partners, as well as the relationship between them. Please verify Molecular Partners standard deviation, information ratio, treynor ratio, as well as the relationship between the variance and jensen alpha to decide if Molecular Partners AG is priced some-what accurately, providing market reflects its recent price of 4.6 per share.
Molecular Partners Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Molecular, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MolecularMolecular |
Molecular Partners technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Molecular Partners Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Molecular Partners Trend Analysis
Use this graph to draw trend lines for Molecular Partners AG. You can use it to identify possible trend reversals for Molecular Partners as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Molecular Partners price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Molecular Partners Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Molecular Partners AG applied against its price change over selected period. The best fit line has a slop of 0.0003 , which means Molecular Partners AG will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Molecular Partners price change compared to its average price change.About Molecular Partners Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Molecular Partners AG on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Molecular Partners AG based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Molecular Partners price pattern first instead of the macroeconomic environment surrounding Molecular Partners. By analyzing Molecular Partners's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Molecular Partners's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Molecular Partners specific price patterns or momentum indicators. Please read more on our technical analysis page.
Molecular Partners January 7, 2025 Technical Indicators
Most technical analysis of Molecular help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Molecular from various momentum indicators to cycle indicators. When you analyze Molecular charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.0524 | |||
Market Risk Adjusted Performance | (0.31) | |||
Mean Deviation | 4.33 | |||
Semi Deviation | 4.75 | |||
Downside Deviation | 5.16 | |||
Coefficient Of Variation | 1853.85 | |||
Standard Deviation | 6.17 | |||
Variance | 38.08 | |||
Information Ratio | 0.0503 | |||
Jensen Alpha | 0.3354 | |||
Total Risk Alpha | 0.229 | |||
Sortino Ratio | 0.0601 | |||
Treynor Ratio | (0.32) | |||
Maximum Drawdown | 40.85 | |||
Value At Risk | (7.99) | |||
Potential Upside | 9.11 | |||
Downside Variance | 26.67 | |||
Semi Variance | 22.53 | |||
Expected Short fall | (4.65) | |||
Skewness | 1.49 | |||
Kurtosis | 5.46 |
Molecular Partners January 7, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Molecular stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 841.90 | ||
Daily Balance Of Power | 0.63 | ||
Rate Of Daily Change | 1.04 | ||
Day Median Price | 4.61 | ||
Day Typical Price | 4.60 | ||
Price Action Indicator | 0.08 |
Additional Tools for Molecular Stock Analysis
When running Molecular Partners' price analysis, check to measure Molecular Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecular Partners is operating at the current time. Most of Molecular Partners' value examination focuses on studying past and present price action to predict the probability of Molecular Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecular Partners' price. Additionally, you may evaluate how the addition of Molecular Partners to your portfolios can decrease your overall portfolio volatility.